The FDA Approves a New HPV Vaccine Containing Over Twice as Much Aluminum As its Predecessor

According to recent reports, the FDA has approved yet another HPV vaccine, despite documented safety issues and the new vaccine containing an exceptionally high level of aluminum, a known neurotoxin. Until now, only two vaccines have been manufactured to protect men and women against human papillomavirus (HPV), a virus believed to be the leading cause of cervical cancer: Cervarix, which is believed to protect against strains 16 and 18 of the virus, and Gardasil, which is believed to protect against strains 6, 11, 16 and 18.   //   A Third HPV Vaccine Hits the Market In December 2014, Gardasil 9 vaccine, manufactured by Merck Sharp and Dohme, was approved by the FDA. This vaccine appears to be somewhat of a “super” vaccine in comparison to the previous versions, as the FDA has claimed it can protect men and women against no less than NINE strains of the HPV virus. In a press release published on December 10, 2014, the FDA stated: “Gardasil 9 is a vaccine approved for use in females ages 9 through 26 and males ages 9 through 15. It is approved for the prevention of cervical, vulvar, vaginal and anal cancers caused by HPV types 16, 18, 31, 33, 45, 52 and 58, and for the prevention of genital warts caused by HPV types 6 or 11. Gardasil 9 adds protection against five additional HPV types—31, 33, 45, 52 and 58— which cause approximately 20 percent of cervical cancers and are not covered by previously FDA-approved HPV vaccines.” Despite the FDAR...
Source: vactruth.com - Category: Allergy & Immunology Authors: Tags: Christina England Physical Top Stories aluminum hydroxide Food and Drug Administration (FDA) Gardasil 9 HPV Vaccine Merck Sharp and Dohme Source Type: blogs